The study met its primary endpoint of radiographic progression free survival, which was significantly prolonged with the ...
At the 2026 PSMA and Beyond annual meeting, Robert Reiter discusses the problems with our PSMA PET reports. Dr. Reiter ...
Impact of BRCA alterations on androgen receptor pathway inhibition treatment outcome in advanced prostate cancer. Predictive associations between serum dehydroepiandrosterone sulfate (DHEAS) and race ...
Prostate-specific membrane antigen (PSMA) is a protein found in small amounts in your prostate gland. When you have prostate cancer, you have many times more PSMA than normal. This makes PSMA a good ...
An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following inconclusive or reassuring results from an MRI scan, new research has found. Findings ...
Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm.
Prostate-specific membrane antigen (PSMA) is a leading target for next-generation prostate cancer therapies, with one FDA-approved medicine and 30 medicines in development Quantitative PSMA-PET ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results